Advertisement

Journal of Molecular Histology

, Volume 50, Issue 4, pp 355–367 | Cite as

MIF/CD74 axis participates in inflammatory activation of Schwann cells following sciatic nerve injury

  • Honghua Song
  • Ziwen Zhu
  • Yue Zhou
  • Nan Du
  • Tiancheng Song
  • Hao Liang
  • Xiaojun Chen
  • Yingjie Wang
  • Yongjun Wang
  • Yuming HuEmail author
Original Paper
  • 115 Downloads

Abstract

Based on deep RNA sequencing of distal segments of lesioned sciatic nerves, a huge number of differentially expression genes (DEGs) were thus obtained and functionally analyzed. The inflammatory response was denoted as one of most significant biological processes following sciatic nerve injury. In the present study, ingenuity pathway analysis (IPA) demonstrated that macrophage migration inhibitory factor (MIF) was identified as a core regulator of inflammatory response through interaction with CD74 membrane receptor. By establishment of rat sciatic nerve transection model, we displayed that MIF was upregulated following sciatic nerve axotomy, in colocalization with Schwann cells (SCs). MIF promoted migration, proliferation, together with inflammatory responses of SCs in vitro. Immunoprecipitation showed that MIF interacted with CD74 receptor, through which to activate intracellular ERK and JNK signaling pathways. Interference of CD74 receptor using specific siRNA showed that the transcription of proinflammatory cytokines including TNF-α, IL-1β, as well as cytokine receptor TLR4 in SCs was significantly attenuated, supporting an participation of MIF/CD74 signal axis in SCs inflammatory response. The data provide a novel role of MIF in eliciting inflammatory response of peripheral nerve injury, which might be beneficial for precise therapy of peripheral nerve inflammation.

Keywords

Peripheral nerve injury RNA sequencing Ingenuity pathway analysis Inflammatory response MIF Schwann cells 

Notes

Acknowledgements

This study was supported by the Basic Scientific Research Projects of Nantong (JC2018065).

Compliance with ethical standards

Ethical approval

Animal experiments were performed in strict accordance with the Institutional Animal Care guidelines.

Supplementary material

10735_2019_9832_MOESM1_ESM.xlsx (30.3 mb)
Supplementary material 1 (XLSX 30,996 kb)

References

  1. Akira S, Sato S (2003) Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 35(9):555–562Google Scholar
  2. Benedek G, Meza-Romero R, Jordan K, Zhang Y, Nguyen H, Kent G, Li J, Siu E, Frazer J, Piecychna M, Du X, Sreih A, Leng L, Wiedrick J, Caillier SJ, Offner H, Oksenberg JR, Yadav V, Bourdette D, Bucala R, Vandenbark AA (2017) MIF and D-DT are potential disease severity modifiers in male MS subjects. Proc Natl Acad Sci USA. 114(40):E8421–E8429Google Scholar
  3. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587–596Google Scholar
  4. Bezdek S, Leng L, Busch H, Mousavi S, Rades D, Dahlke M, Zillikens D, Bucala R, Sadik CD (2018) Macrophage migration inhibitory factor (MIF) drives murine psoriasiform dermatitis. Front Immunol 9:2262Google Scholar
  5. Bhatheja K, Field J (2006) Schwann cells: origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol 38(12):1995–1999Google Scholar
  6. Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153(3731):80–82Google Scholar
  7. Boivin A, Pineau I, Barrette B, Filali M, Vallières N, Rivest S, Lacroix S (2007) Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 27(46):12565–12576Google Scholar
  8. Bombeiro AL, Santini JC, Thomé R, Ferreira ER, Nunes SL, Moreira BM, Bonet IJ, Sartori CR, Verinaud L, Oliveira AL (2015) Enhanced immune response in immunodeficient mice improves peripheral nerve regeneration following axotomy. Front Cell Neurosci 10:151Google Scholar
  9. Bruno K, Woller SA, Miller YI, Yaksh TL, Wallace M, Beaton G, Chakravarthy K (2008) Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states. Pain 159(10):1908–1915Google Scholar
  10. Calandra T (2003) Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 35(9):573–576Google Scholar
  11. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800Google Scholar
  12. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377(6544):68–71Google Scholar
  13. Fagone P, Mazzon E, Cavalli E, Bramanti A, Petralia MC, Mangano K, Al-Abed Y, Bramati P, Nicoletti F (2018) Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences. J Neuroimmunol 322:46–56Google Scholar
  14. Gaudet AD, Popovich PG, Ramer MS (2011) Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation. 8:110Google Scholar
  15. Goethals S, Ydens E, Timmerman V, Janssens S (2010) Toll-like receptor expression in the peripheral nerve. Glia 58(14):1701–1709Google Scholar
  16. Günther S, Fagone P, Jalce G, Atanasov AG, Guignabert C, Nicoletti F (2019) Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets. Drug Discov Today 24(2):428–439Google Scholar
  17. Guo Q, Zhu H, Wang H, Zhang P, Wang S, Sun Z, Li S, Xue C, Gu X, Cui S (2018) Transcriptomic landscapes of immune response and axonal regeneration by integrative analysis of molecular pathways and interactive networks post-sciatic nerve transection. Front Neurosci 12:457Google Scholar
  18. Hertelendy J, Reumuth G, Simons D, Stoppe C, Kim BS, Stromps JP, Fuchs PC, Bernhagen J, Pallua N, Grieb G (2018) Macrophage migration inhibitory factor—a favorable marker in inflammatory diseases? Curr Med Chem 25(5):601–605Google Scholar
  19. Hongqi L, Manfred D, Lin L, Richard B (2011) Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR40 and CD74. Cell Signal 23(1):135–144Google Scholar
  20. Jessen KR, Mirsky R, Lloyd AC (2015) Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol 7(7):a020487Google Scholar
  21. Lang T, Lee JPW, Elgass K, Pinar AA, Tate MD, Aitken EH, Fan H, Creed SJ, Deen NS, Traore DAK, Mueller I, Stanisic D, Baiwog FS, Skene C, Wilce MCJ, Mansell A, Morand EF, Harris J (2018) Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation. Nat Commun 9(1):2223Google Scholar
  22. Lechien JR, Nassri A, Kindt N, Brown DN, Journe F, Saussez S (2017) Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: a systematic review. Head Neck 39(12):2573–2584Google Scholar
  23. Lee H, Lee S, Cho IH, Lee SJ (2013) Toll-like receptors:sensor molecules for detecting damage to the nervous system. Curr Protein Pept Sci 14(1):33–42Google Scholar
  24. Lee H, Baek J, Min H, Cho IH, Yu SW, Lee SJ (2016) Toll-like receptor 3 contributes to Wallerian degeneration after peripheral nerve injury. NeuroImmunoModulation 23(4):209–216Google Scholar
  25. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197(11):1467–1476Google Scholar
  26. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J (2006) Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 18(5):688–703Google Scholar
  27. Man LL, Liu F, Wang YJ, Song HH, Xu HB, Zhu ZW, Zhang Q, Wang YJ (2015) The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. Neural Regen Res 10(10):1706–1712Google Scholar
  28. Mangano K, Mazzon E, Basile MS, Di Marco R, Bramanti P, Mammana S, Petralia MC, Fagone P, Nicoletti F (2018) Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. Oncotarget 9(25):17951–17970Google Scholar
  29. Merk M, Zierow S, Leng L, Das R, Du X, Schulte W, Fan J, Lue H, Chen Y, Xiong H, Chagnon F, Bernhagen J, Lolis E, Mor G, Lesur O, Bucala R (2011) The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Natl Acad Sci U S A 108(34):E577–E585Google Scholar
  30. Mitchell RA, Metz CN, Peng T, Bucala R (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274(25):18100–18106Google Scholar
  31. Morand EF, Leech M, Bernhagen J (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5(5):399–410Google Scholar
  32. Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, Rosenberg LH, Collins MJ, Harrisingh MC, White IJ, Woodhoo A, Lloyd AC (2012) A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73(4):729–742Google Scholar
  33. Nishio Y, Minami A, Kato H, Kaneda K, Nishihira J (1999) Identification of macrophage migration inhibitory factor (MIF) in rat peripheral nerves: its possible involvement in nerve regeneration. Biochim Biophys Acta 1453(1):74–82Google Scholar
  34. Nishio Y, Nishihira J, Ishibashi T, Kato H, Minami A (2002) Role of macrophage migration inhibitory factor (MIF) in peripheral nerve regeneration: anti-MIF antibody induces delay of nerve regeneration and the apoptosis of Schwann cells. Mol Med 8(9):509–520Google Scholar
  35. Nobre CC, de Araújo JM, Fernandes TA, Cobucci RN, Lanza DC, Andrade VS, Fernandes JV (2017) Macrophage migration inhibitory factor (MIF): biological activities and relation with cancer. Pathol Oncol Res 23(2):235–244Google Scholar
  36. Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M (2012) Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells. J Cell Sci 125(Pt 13):3210–3220Google Scholar
  37. Presti M, Mazzon E, Basile MS, Petralia MC, Bramanti A, Colletti G, Bramanti P, Nicoletti F, Fagone P (2018) Presti M Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR31 and CXCR31, in glioblastoma. Oncol Lett 16(3):2881–2886Google Scholar
  38. Roger T, David J, Glauser MP, Calandra T (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414(6866):920–924Google Scholar
  39. Roger T, Froidevaux C, Martin C, Calandra T (2003) Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4). J Endotoxin Res 9(2):119–123Google Scholar
  40. Rotshenker S (2011) Wallerian degeneration:the innate-immune response to traumatic nerve injury. J Neuroinflamm 8:109Google Scholar
  41. Santos LL, Morand EF (2006) The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien Med Wochenschr 156(1–2):11–18Google Scholar
  42. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25(4):595–606Google Scholar
  43. Shin YK, Jang SY, Yun SH, Choi YY, Yoon BA, Jo YR, Park SY, Pak MG, Park JI, Park HT (2017) Cooperative interaction of hepatocyte growth factor and neuregulin regulates Schwann cell migration and proliferation through Grb2-associated binder-2 in peripheral nerve repair. Glia. 65(11):1794–1808Google Scholar
  44. Tohyama S, Onodera S, Tohyama H, Yasuda K, Nishihira J, Mizue Y, Hamasaka A, Abe R, Koyama Y (2008) A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis. Gene Ther 15(23):1513–1522Google Scholar
  45. Wang L, Sanford MT, Xin Z, Lin G, Lue TF (2015) Role of Schwann cells in the regeneration of penile and peripheral nerves. Asian J Androl 17(5):776–782Google Scholar
  46. Wang Y, Zhao Y, Sun C, Hu W, Zhao J, Li G, Zhang L, Liu M, Liu Y, Ding F, Yang Y, Gu X (2016) Chitosan degradation products promote nerve regeneration by stimulating Schwann cell proliferation via miR-27a/FOXO1 axis. Mol Neurobiol 53(1):28–39Google Scholar
  47. Wang X, Ma S, Wu H, Shen X, Xu S, Guo X, Bolick ML, Wu S, Wang F (2018) Macrophage migration inhibitory factor mediates peripheral nerve injury-induced hypersensitivity by curbing dopaminergic descending inhibition. Exp Mol Med 50(2):e445Google Scholar
  48. Yi S, Zhang H, Gong L, Wu J, Zha G, Zhou S, Gu X, Yu B (2016) Deep sequencing and bioinformatic analysis of lesioned sciatic nerves after crush injury. PLoS ONE 10(12):e0143491Google Scholar
  49. Yu J, Gu X, Yi S (2016) Ingenuity pathway analysis of gene expression profiles in distal nerve stump following nerve injury: insights into Wallerian degeneration. Front Cell Neurosci 10:274Google Scholar
  50. Zhang X, Gong X, Qiu J, Zhang Y, Gong F (2017) MicroRNA-210 contributes to peripheral nerve regeneration through promoting the proliferation and migration of Schwann cells. Exp Ther Med 14(4):2809–2816Google Scholar
  51. Zhang H, Shao Z, Zhu Y, Shi L, Li Z, Hou R, Zhang C, Yao D (2018) Toll-like receptor 4 (TLR4) expression affects Schwann cell behavior in vitro. Sci Rep 8(1):11179Google Scholar
  52. Zhao Y, Wang Y, Gong J, Yang L, Niu C, Ni X, Wang Y, Peng S, Gu X, Sun C, Yang Y (2017) Chitosan degradation products facilitate peripheral nerve regeneration by improving macrophage-constructed microenvironments. Biomaterials 134:64–77Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Honghua Song
    • 1
  • Ziwen Zhu
    • 2
  • Yue Zhou
    • 3
  • Nan Du
    • 2
  • Tiancheng Song
    • 2
  • Hao Liang
    • 2
  • Xiaojun Chen
    • 2
  • Yingjie Wang
    • 2
  • Yongjun Wang
    • 2
  • Yuming Hu
    • 3
    Email author
  1. 1.Department of PediatricsAffiliated Hospital of Nantong UniversityNantongPeople’s Republic of China
  2. 2.Key Laboratory of Neuroregeneration of Jiangsu and Ministry of EducationNantong UniversityNantongPeople’s Republic of China
  3. 3.Department of Rehabilitation MedicineAffiliated Hospital of Nantong UniversityNantongPeople’s Republic of China

Personalised recommendations